Plant-Derived Polysaccharides as Modulators of the Gut–Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Keywords:
gut–liver axis, metabolic dysfunction-associated steatotic liver disease, plant polysaccharides, systems architecture, microbiota, resilience, infrastructure governanceAbstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a global health challenge, driven by intertwined dietary, microbial, and host metabolic perturbations. The gut–liver axis constitutes a bidirectional communication system whose architecture integrates intestinal barrier integrity, microbial ecology, bile acid signaling, and immune surveillance. Within this complex adaptive system, plant-derived polysaccharides exhibit a striking capacity to orchestrate multi-level modulatory effects that extend far beyond their traditional classification as dietary fibers. This paper presents a systems-level analysis of how structurally diverse polysaccharides interface with the gut–liver axis, emphasizing architectural trade-offs, network robustness, governance of physiological boundaries, and deployment considerations. Rather than cataloging molecular interactions in isolation, we characterize the gut–liver axis as a layered infrastructure with modular functional units, feedback regulation, and emergent properties that determine resilience against steatotic insults. Plant polysaccharides are positioned as soft modulators that engage multiple nodes simultaneously, enabling context-dependent reconfiguration of microbial consortia, reinforcement of epithelial barrier architecture, and tuning of hepatic inflammatory and metabolic circuits. The discussion extends to structural trade-offs among polysaccharide complexity, fermentability, and site-specific activity, highlighting how source-dependent molecular topologies influence system-level outcomes. Further, we examine the infrastructure required for scalable production, standardization, and equitable deployment of polysaccharide-based interventions, addressing sustainability of raw material supply chains and regulatory governance challenges that straddle the boundaries between food, supplement, and therapeutic agent. By reframing polysaccharide action through the lens of systems architecture and policy, this analysis reveals the deep coupling between molecular design, ecological resilience, and societal implementation that must be navigated to translate gut–liver axis modulation into population-wide metabolic health benefits.
References
1. Sonoda, J., Pei, L., & Evans, R. M. (2008). Nuclear receptors: Decoding metabolic disease. FEBS Letters, 582(1), 2–9.
2. Wahlström, A., Sayin, S. I., Marschall, H. U., & Bäckhed, F. (2016). Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metabolism, 24(1), 41–50.
3. Larsen, N., Bussolo de Souza, C., Krych, L., Cahu, T. B., Wiese, M., Kot, W., Hansen, K. M., Blennow, A., Venema, K., & Jespersen, L. (2019). Potential of pectins to beneficially modulate the gut microbiota depends on their structural properties. Frontiers in Microbiology, 10, 223.
4. Ndeh, D., & Gilbert, H. J. (2018). Biochemistry of complex glycan depolymerisation by the human gut microbiota. FEMS Microbiology Reviews, 42(2), 146–164.
5. El Khoury, D., Cuda, C., Luhovyy, B. L., & Anderson, G. H. (2012). Beta glucan: Health benefits in obesity and metabolic syndrome. Journal of Nutrition and Metabolism, 2012, 851362.
6. Hamer, H. M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F. J., & Brummer, R. J. (2008). Review article: The role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics, 27(2), 104–119.
7. Peng, L., Li, Z. R., Green, R. S., Holzman, I. R., & Lin, J. (2009). Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. Journal of Nutrition, 139(9), 1619–1625.
8. Miura, K., & Ohnishi, H. (2014). Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World Journal of Gastroenterology, 20(23), 7381–7391.
9. Ridlon, J. M., Kang, D. J., & Hylemon, P. B. (2006). Bile salt biotransformations by human intestinal bacteria. Journal of Lipid Research, 47(2), 241–259.
10. Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., Pellicciari, R., Auwerx, J., & Schoonjans, K. (2009). TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metabolism, 10(3), 167–177.
11. Brown, G. D., & Gordon, S. (2003). Fungal beta-glucans and mammalian immunity. Immunity, 19(3), 311–315.
12. Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020). Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders. Nature Reviews Gastroenterology & Hepatology, 17(5), 279–297.
13. Rivière, A., Selak, M., Lantin, D., Leroy, F., & De Vuyst, L. (2016). Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. Frontiers in Microbiology, 7, 979.
14. Cui, S. W., & Wang, Q. (2009). Cell wall polysaccharides in cereals: Chemical structures and functional properties. Structural Chemistry, 20(2), 291–297.
15. Pettolino, F. A., Walsh, C., Fincher, G. B., & Bacic, A. (2012). Determining the polysaccharide composition of plant cell walls. Nature Protocols, 7(9), 1590–1607.
16. Zhao K, et al. Phyllostachys nigra (Lodd ex Lindl) derived polysaccharide with enhanced glycolipid metabolism regulation and mice gut microbiome. Int J Biol Macromol. 2024;257:128588.
17. Buck, M., & Hamilton, C. (2011). The Nagoya Protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization to the Convention on Biological Diversity. Review of European Community & International Environmental Law, 20(1), 47–61.
18. Jalili-Firoozinezhad, S., Gazzaniga, F. S., Calamari, E. L., Camacho, D. M., Fadel, C. W., Bein, A., Swenor, B., Nestor, B., Cronce, M. J., Tovaglieri, A., Levy, O., Gregory, K. E., Breault, D. T., Cabral, J. M. S., Kasper, D. L., Novak, R., & Ingber, D. E. (2019). A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nature Biomedical Engineering, 3(7), 520–531.
19. Thiele, I., Sahoo, S., Heinken, A., Hertel, J., Heirendt, L., Aurich, M. K., & Fleming, R. M. (2020). Personalized whole-body models integrate metabolism, physiology, and the gut microbiome. Molecular Systems Biology, 16(5), e8982.
20. Hess, S., Laimer, M., & Wascher, D. (2019). Policy options for sustainable food environments: A conceptual framework for public and private governance. Food Policy, 82, 63–74.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 International Journal of Clinical and Translational Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
This article is published under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
